BECKER MUSCULAR DYSTROPHY
Clinical trials for BECKER MUSCULAR DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new BECKER MUSCULAR DYSTROPHY trials appear
Sign up with your email to follow new studies for BECKER MUSCULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for slowing becker MD in Long-Term trial
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety and effects of a drug called EDG-5506 (sevasemten) in adults and teenagers with Becker muscular dystrophy, a muscle-weakening disease. About 260 people who have already been in earlier EDG-5506 studies will take the drug and be monitored f…
Matched conditions: BECKER MUSCULAR DYSTROPHY
Phase: PHASE2 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New drug hopes to slow muscle damage in becker MD
Disease control OngoingThis study tests an experimental drug called sevasemten (EDG-5506) in 244 adults and adolescents with Becker muscular dystrophy, a genetic condition that causes progressive muscle weakness. Participants receive either the drug or a placebo to see if it is safe and can improve mus…
Matched conditions: BECKER MUSCULAR DYSTROPHY
Phase: PHASE2 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC